Every year, I think this is it, we’ve reached the pinnacle. And yet, every year, I continue to be amazed by the individuals whom our readers have identified as the most inspiring, motivating, and outstanding leaders in the life-science industry. This special issue, now its sixth year, has become a must-read and one of the…

HORSHAM, Pa. – June 29, 2010 – The first health care market research company to listen to, analyze and deliver nationwide insights derived from naturally-occurring dialogue between patients and physicians,Verilogue today announced it has captured more than 50,000 physician-patient conversations across the continuum of care, from routine well visits to the heartfelt delivery of metastatic…

The battle for the hearts, minds and prescription pads of physicians treating targeted patients has always been challenging, but competitive pressures have never been more intense. Impending patent expirations threaten to expose billions of dollars in branded products to generic erosion. Mounting regulatory pressures, feverish political climate and lukewarm economic conditions place even greater restrictions…

REMS programs. Megamergers. Generic encroachment. New sampling guidelines. The “unknowns” in the pharma industry have never been more prevalent or complex. But despite volumes of lagging prescription data and recall-based market research, pharma is still struggling to understand and anticipate how each new industry issue will impact current and future success. The key to understanding…

This past September, Med Ad News began its now-annual search for the future of pharmaceutical marketing. We sought out young companies to profile that are providing the most innovative and interesting products, services, or marketing opportunities to pharmaceutical companies and the healthcare community. After reviewing dozens of nominations, many of which were provided by our…